# TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma

> **NCT01328574** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 13 (actual)

## Conditions studied

- Urothelial Carcinoma
- Ureteral Neoplasms
- Ureter Cancer
- Neoplasm, Ureteral
- Cancer of the Ureter

## Interventions

- **DRUG:** TRC105

## Key facts

- **NCT ID:** NCT01328574
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2014-05
- **Final completion:** 2014-11
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2017-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01328574

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01328574, "TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01328574. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*